Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$URBF is not here, SEC Rule 15c2-11 Restricted Securities
does anyone understand?
https://www.schwab.com/resource/otcexpertmarket
Large volume $TRON + 50% 12X13 this goes very high
The SPAC Bubble Is Burst. It May Be Time to Invest.
While the SPAC boom has fizzled, blank-check vehicles are now trading at deep enough discounts for even skeptical investors to consider arbitrage trades
https://www.wsj.com/articles/the-spac-bubble-is-burst-it-may-be-time-to-invest-11631619621
Short $TONR with problems ?
$TONR Filings are out Only attorney letter is left :
https://www.otcmarkets.com/stock/TONR/disclosure
VERY GOOD NEWS let's see if charles schwab allows you to trade now $EXLA
https://www.otcmarkets.com/stock/EXLA/security
the Bilden government after a year has to start moving chips on subsidies, aid etc ... $ITOX is a strategic company, it has all the numbers to end up on the Nasdaq, it is a quantion of time
is there a way to know if it is one buyer or several? that MMS demands those actions?
It seems that $JPEX is beginning to move despite the restrictions, hopefully it will be one of the first to be liberalized!
How can the new SEC rule affect LAZAR companies?
$XNNHQ $TRDX
Hello friend Value, these companies won't let you buy them CS, don't you think that they will probably disappear on the 27th ?
U.S. Puts $562 Billion Price Tag on Ramping Up Solar Power
Energy Department says U.S. could get 44% of its electricity from solar energy if it pursues aggressive agenda
The U.S. could get 37% of its electricity from solar power by 2035—and 44% by 2050—if the U.S. pursues an ambitious agenda to cut reliance on fossil fuels, the Energy Department said Wednesday.
The Energy Department says the U.S. now gets 3% of its power from solar sources, requiring rapid growth if the country aims to eliminate greenhouse-gas emissions from its power sector. The Energy Department report said ramping up solar power to the 44% level would require an increase in spending by the public and private sector of as much as $562 billion between 2020 and 2050.
https://www.wsj.com/articles/u-s-could-get-44-of-its-electricity-from-solar-power-by-2050-report-says-11631114263
Thank you for your contributions to be all calmer to see if the price remains above 0.020
waiting for catalysts in $JPEX ¡¡
Large volume $BYOC who accumulates at these prices?
Psychedelic Stocks Chasing Medical Treatment Markets With Combined Value Of $330B
Current psychedelic drug R&D involving human testing is already proceeding in treatment markets with a combined value of $330 billion in annual revenues
Pre-clinical psychedelics-based research is targeting additional treatment markets valued in the $100s of billions
The combined market cap of public companies pursuing this research is below $10 billion
Psychedelic drugs were in the news again this week. A very enthusiastic article from the BBC detailed the “psychedelic renaissance”.
Drugs that have been wrongfully criminalized for ~50 years are poised to revolutionize healthcare, in general, and (in particular) the treatment of mental health disorders. The BBC noted that:
Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction. The response from the psychiatric community, far from dismissive or even sceptical, has been largely open-armed. The drugs may well mark the field’s first paradigm shift since SSRIs in the 1980s. [emphasis mine]
Regular readers of Psychedelic Stock Watch have seen similar reporting on a regular basis. But the BBC’s message is being received not only by (current) investors in psychedelics but its entire mainstream audience.
A new healthcare trend, a treatment population of 2 billion people
Large opportunities in major treatment markets are being broadcast to the public by a major media outlet. That should be enough to get the attention of a lot of investors.
The BBC continued:
If current trends continue, it may be a matter of time until psychedelic-assisted psychotherapy is green-lighted by regulators. In a decade's time, might clinics and hospitals feature Psychedelic Session Rooms kitted out with cushions, incense, candles and paintings?
For investors wondering how big this “trend” could get, Psychedelic Stock Watch has previously laid out the Big Picture. Globally, there are ~2 billion people with treatable (but generally untreated) mental health disorders. Approximately 1 out of 4 people around the world.
Nearly an inexhaustible supply of patients stand ready to take advantage of next-generation mental health therapies featuring psychedelic drugs.
Why are these mental health disorders generally “untreated”? Because existing therapy options range from mediocre to abysmal. We have catalogued this litany of failure on many occasions.
Addiction therapy is largely a revolving door, because conventional drugs cannot control addictive cravings.
First-line drugs to treat depression are only effective for roughly 50% of patients, and 1/3rd of that is just a placebo effect. Two-thirds of Americans exhibiting symptoms of depression don’t even seek treatment due to inadequate treatment options.
In the U.S. military, an average of 22 veterans per day are committing suicide. Yet only 1/3rd of veterans receiving treatment for PTSD report any benefit from treatment.
Untreated mental health disorders, with catastrophic costs. Altogether, these mental health disorders lead to ~8 million preventable deaths per year. In economic terms, the failure to treat these mental health disorders costs the global economy trillions of dollars each year.
In total, this untreated mental health catastrophe is now commonly referred to as “the Mental Health Crisis”.
Massive revenue potential for psychedelic drugs in major treatment markets
Psychedelic drugs are capturing most of their headlines in the mainstream media due to their amazing capacity to successfully treat these mental health disorders. And Psychedelic Stock Watch has reviewed the R&D picture here.
However, the medicinal potential of psychedelic drugs goes well beyond these stress-related mental health disorders. Advancing research is showing psychedelics to be the ultimate brain-repair drugs – thus opening up numerous other treatment markets for potential research.
Looking at the treatment markets where there has already been human research (from formal clinical trials all the way down to informal empirical data), current psychedelic drug R&D is targeting treatment markets expected to reach a combined value of $330 billion before the end of this decade.
In the United States alone, an estimated 1.7 million Americans suffer traumatic brain injuries (TBIs) each year. As with stress-related mental health disorders, existing treatment options offer only mediocre therapy results.
While professional athletes are the most-visible demographic in need of much better treatment options, this is a vast overall treatment market – forecast to reach $182 billion in size by 2027.
The treatment market for nicotine addiction is also vast. With roughly 1 billion addicts globally, this treatment market is expected to grow to $64 billion by 2026.
But the best existing “smoking cessation” products generate a success rate of only ~30%. The most popular of these drugs was generating over $1 billion per year in revenues – before it was recalled due to harmful side effects.
A 2014 clinical study by Johns Hopkins using psilocybin-based therapy to treat nicotine addiction reported that 80% of participants were still fully abstinent 6 months later. How much bigger would the nicotine addiction treatment market get if there was a therapy on the market that actually worked? And psilocybin is also an extremely safe substance.
According to the CDC, more than two-thirds of American cigarette smokers want to quit – but can’t.
The story is the same with other forms of substance abuse/addiction. Existing treatment options provide little more than minimally effective crutches. Clinical research is showing that psychedelic drugs can deliver cures.
Estimates on the future size of the depression treatment market are also likely very conservative, for similar reasons. Existing treatments don’t work. Consequently, most people don’t even seek treatment.
Clinical studies are demonstrating the clear potential of psychedelic medicine to cure depression.
In short, these treatment markets will likely grow even larger because of the success rate of psychedelic medicine. And because these therapies represent such enormous (potential) improvements versus the existing standard of care, they can be expected to claim major market share over the long term.
Massive investment opportunity, cheap psychedelic stocks
The psychedelic drug industry is an emerging industry, with public companies little more than 1 year old. But clinical research is already advanced, including Phase IIb and even Phase III clinical trials currently underway.
As already noted, the treatment markets being targeted by this research are projected to be worth a combined $330 billion in annual revenues. Yet the market cap of the entire industry (among public companies) is less than $10 billion.
That is a lot of upside potential.
Not surprisingly, institutional investors are already providing strong financial support for this industry. Public companies alone have now raised in excess of $1 billion. Financings are almost always upsized and oversubscribed.
There is little doubt that these companies will be (well) financed to make it to the finish line in their drug development – in what is a capital-intensive industry.
The fundamentals for the psychedelic drug industry are about as bullish as it gets for investors in life science companies.
Huge treatment populations
Huge treatment markets
Huge improvements on the existing standard of care
Abundant capital for R&D
Early investors in this space have already seen the investment potential of these companies. During a major run last fall, several companies produced ten-baggers for investors.
In 2021, gains have been much more muted. Most companies sit well below their 52-week highs. Despite the magnitude of the investment opportunity here, these psychedelic stocks are cheap.
Even more blue-sky potential
The picture above only covers opportunities in psychedelic drug research where there is already some human testing occurring. A massive and growing volume of additional psychedelics-based research is taking place at the pre-clinical level.
Chronic pain is one of the largest treatment markets. Estimated to become a $151.7 billion treatment market by 2030. The potential of psychedelic medicine here is more than theoretical.
Ketamine, the only currently legal psychedelic drug, has already been used off-label in pain management. However, other psychedelic drugs are seen as having even more potential here and a flurry of pre-clinical research is already underway.
With obesity being a growing problem in our societies (no pun intended), weight management R&D is now being enthusiastically pursued by several public companies at the pre-clinical level. The obesity treatment market is expected to reach $27.1 billion by 2028.
New research on autoimmune disorders is focusing on a “psychosocial” root to these diseases. Psychedelics-based R&D is targeting this enormous treatment market, forecast to grow to $108 billion by 2023.
In other words, treating mental health disorders is only a starting point for this emerging industry – not the endpoint.
The two billion people with treatable mental health disorders are currently the focus of most psychedelic drug R&D. Further down the road, additional multi-billion-dollar treatment markets and 100s of millions more potential patients/consumers offer immense blue-sky potential.
There are no viable treatment options for psychedelics in treating mental health anywhere on the visible horizon. Mental health disorders are at catastrophic levels.
A humanitarian crisis. An economic crisis.
Governments must legalize and commercialize psychedelic medicine to address this medical catastrophe. And when they do, investors now have a price-tag on the magnitude of this commercial opportunity.
Drug markets (cover) by N/A is licensed under Adobe Stock
https://psychedelicstockwatch.com/psychedelic-stock-news/psychedelic-stocks-chasing-medical-treatment-markets-with-combined-value-of-330b
I think $EXLA is going to have an EPICA rise, for days it cannot be bought but it can be sold, EXLA is a company that has submitted the two data to the SEC and we are waiting for the OTC MARKETS website to update
$ EXLA HAS BEEN WORKING FOR MONTHS TO UPDATE:
The new website and presentation of the new business about to be published
http://exlaresources.com/
Ecoark $ZEST Secures Power Capacity for Cryptocurrency Mining Beta Site Development in Texas First Phase Expected to Become Operational in approximately 90 days
SAN ANTONIO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Ecoark Holdings, Inc. (“Ecoark”) (NASDAQ: ZEST), announced that its indirect wholly owned subsidiary Bitstream Mining LLC (“Bitstream”), a wholly owned subsidiary of Trend Discovery Holdings LLC (“Trend”) entered into an agreement on September 3, 2021, to secure 12 MW (“megawatts”) of available electric capacity for Bitstream’s mining operation. Specific terms of the agreement will be disclosed at a future date. Bitstream and its strategic power consultant are working with the utility to upgrade the utility’s substation in order to expand the available capacity up to 50 MW.
Ecoark previously announced that Bitstream would be developing a 6 MW cryptocurrency mining operation in Texas. Brad Hoagland, CFA, Chief Financial Officer of Ecoark commented, “We are proud to have upheld and outperformed our commitment by securing power capacity within 30-days, while also doubling the target capacity of our mining operation from 6 MW to 12 MW and initiating an expansion to 50 MW. We remain confident that Bitstream’s projected high margin business model will fulfill one of the key business lines within Trend for its recently announced and upcoming spin-off transaction into a pure play FinTech company.”
Bitstream has also secured mining equipment with delivery anticipated within the targeted operational timeline. Bitstream expects to participate in the Electric Reliability Council of Texas’ (ERCOT) responsive reserve market as part of our Environmental, Social, and Governance (“ESG”) strategy by relinquishing its power back to the Texas grid as warranted. “We plan to utilize our operational load flexibility to participate in the ERCOT market and provide ERCOT with more tools to help stabilize the grid when needed”, stated M. Britt Swann, President of Bitstream
Justice is slow, perhaps EMA has been advised and wants to agree with CYAP ... EMA exceeded? 15 million for CYAP is huge
I think that after Friday's rise there is something
EMA provided successive conversion notices to the Company and its transfer agent, which resulted in EMA being issued 18,369,800 shares of Cyber App’s common stock. Through its sales of this stock, the Company’s share price declined from by over 90% from $0.102 on April 6, 2021, to $0.009 on May 23, 2021.
$CYAP Files Lawsuit Against EMA Financial LLC for Over $15 Million in Damages
LAS VEGAS, NV / ACCESSWIRE / June 10, 2021 / Further to its news release dated May 3, 2021, Cyber Apps World Inc. (OTC PINK:CYAP) (“Cyber Apps” or the “Company”), an acquirer and developer of innovative cyber technologies with the potential for disruptive scalability and eventual spin-off success, announces that it has commenced legal action against EMA Financial, LLC’s (“EMA”) in Nevada District Court for breach of contract claims relating to a share purchase agreement and corresponding convertible promissory note.
In March 2021, Cyber Apps attempted to prepay EMA’s convertible promissory note for the premium stipulated in the note, but EMA, relying on a most favored nation clause, took the position that the payout amount was significantly higher than the amount that Cyber Apps believed was due. Cyber Apps’ legal counsel put EMA on notice that the Company disputed the prepayment amount due pursuant to the note.
On April 6, 2021, EMA provided Cyber Apps and its transfer agent with a notice of conversion whereby it instructed the transfer agent to convert the entire principal amount of the note, plus interest, for 1,281,682 shares of the Company. Because the note contains a clause that allows EMA to cancel the conversion if the shares are not issued within one business day of the conversion notice, EMA canceled the conversion on April 8 following the decline in Cyber Apps’ stock price. The transfer agent advised Cyber Apps that it could not issue the converted shares by the one business day deadline because EMA did not provide it with the necessary documentation to effect the conversion and issue the shares.
EMA provided successive conversion notices to the Company and its transfer agent, which resulted in EMA being issued 18,369,800 shares of Cyber App’s common stock. Through its sales of this stock, the Company’s share price declined from by over 90% from $0.102 on April 6, 2021, to $0.009 on May 23, 2021.
Cyber Apps was ready, willing, and able to prepay EMA’s note for the amount originally stated in the note by the prepayment deadline date and suffered damages due to EMA’s failure to accept that prepayment. Moreover, the Company alleges that EMA acted in bad faith by providing notice of conversion of its note to its transfer agent and then failing to provide the transfer agent with the documentation necessary to effect the conversion so that it could withdraw the conversion if Cyber Apps’ stock price subsequently fell or proceed with the conversion if the stock value increased or remained stable.
The Company is seeking damages of $15,256,438 for its decrease in market capitalization due to the wrongful actions of EMA, as well as punitive and other damages.
09/03/2021 Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information
https://www.otcmarkets.com/stock/EXLA/disclosure
Great $JPEX closing day, let's see if this long weekend we have any great news!
Great day at $INCC Good weekend
Cyber Apps ($CYAP) Files Lawsuit Against Black Ice Advisors LLC for Significant Damages in Connection with Convertible Promissory Note
LAS VEGAS, NV / ACCESSWIRE / July 28, 2021 / Cyber Apps World Inc. (OTCMKTS:CYAP) ("Cyber Apps" or the "Company") (Cyberappsworld.com), an acquirer and developer of innovative cyber technologies with the potential for disruptive scalability and eventual spin-off success, announces that it has commenced legal action against Black Ice Advisors LLC ("Black Ice") in Nevada District Court for breach of contract claims relating to a share purchase agreement and corresponding convertible promissory note.
Pursuant to the convertible promissory note, on May 3, 2021, Black Ice converted $38,330 in debt into 3,833,000 shares of common stock in the capital of Cyber Apps. On June 3, 2021, Black Ice provided Cyber App's transfer agent with another notice of conversion whereby it converted another $56,310 into 5,631,000 Cyber Apps shares, which Black Ice received and then immediately sold into the market. However, at the time of the second conversion, Cyber Apps only owed $22,045 to Black Ice. Accordingly, Black Ice received and sold 3,426,500 to which it was not entitled.
As a result of Black Ice's excess conversion, Cyber Apps suffered damages due to the dilution to its share capital and Black Ice realized a monetary benefit from the receipt and sale of the shares to which it was not entitled. Cyber Apps is seeking damages that include the disgorgement of the profits that Black Ice wrongfully received, as well as compensation for the adverse impact on Cyber App's market price and the loss of business that it suffered as a result of the inability to raise further financing.
About Cyber Apps World Inc.
Cyber Apps World, Inc. is a company that is dedicated to acquiring and developing a worldwide e-commerce internet platform with the purchase and sale of products and services by way of mobile/computer applications worldwide. Cyber Apps World anticipates making available to subscribers, an ever-growing list of applications and programs.
For more information go to: https://cyberappsworld.com
Forward-Looking Statements
This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. That includes the possibility that the legal action outlined in this press release cannot proceed for some reason. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Cyber Apps World, Inc. to be materially different from the statements made herein. Except for any obligation under the U.S. federal securities laws, Cyber Apps World, Inc. undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.
Company Address
9436 W. Lake Mead Blvd.
Suite 5-53
Las Vegas, NV 89134
Phone: (702) 805-0632
For All Inquiries Contact:
info@cyberappsworld.com
SOURCE: Cyber Apps World Inc.
View source version on accesswire.com:
https://www.accesswire.com/657447/Cyber-Apps-CYAP-Files-Lawsuit-Against-Black-Ice-Advisors-LLC-for-Significant-Damages-in-Connection-with-Convertible-Promissory-Note
Aomething big is cooked in $CYAP new highs 0.017 YEARRR
At the moment it seems there is no dissolution or issuance of new shares
https://www.otcmarkets.com/stock/CYAP/security
the company is totally up to date, PINK ¡¡
I would like, do you think that after $CYAP there is some APP with great interest on the part of a large company such as AMAZON, GOOGLE etc ... everything can be ¡¡
they seem to have run out of stock ... now waiting for some good catalysts at $BYOC
remember that Monday is a holiday
I see that on the $CYAP website they present 4 APP, does anyone have more information about them? Have they been tested and are they working?
https://cyberappsworld.com/index.php/smartsavenow/
any news on $CYAP ? It seems that the alarms are going to start to go off GREAT STRUCTURE : https://www.otcmarkets.com/stock/CYAP/security
ASK $EMBR 0,0027 it seems that something is cooking in this possible shell https://www.otcmarkets.com/stock/embr/security
Very good recovery $EXLA ¡¡this is going to be great thanks to its shareholding structure ¡¡
Held at DTC 93,002,409
https://www.otcmarkets.com/stock/EXLA/security
Someone is leaving $EXLA, good opportunity to enter a clean shell
Any news on $TRDX ? COMPANY UP TO DATE ¡¡
https://www.otcmarkets.com/stock/TRDX/security
Let's wait at any moment, and if not, it stabilizes around 0.0300-0.0400
it seems that charles schwab allows to trade $URBF again,
I just realized
Any news on $WNRS ? waiting for your big moment!
until September 28, I trust that some custodian will take charge of this $URBF jewel
Thanks for sharing! I trust that the best of $JPEX is yet to come!